Press Releases for LH

Press Releases
Laboratory Corporation of America® Holdings Announces 2009 Third Quarter Results
BenchmarkJournal.Com Free Analyst Review for SLM, AIV, D, PWE, LH and KR
LabCorp Announces $250 Million Stock Repurchase Program
LabCorp Successfully Completes Acquisition of Monogram Biosciences, Inc.
LabCorp Is Scheduled to Present at the William Blair & Company Personalized Medicine Conference
LabCorp Successfully Completes Cash Tender Offer for Outstanding Shares of Monogram Biosciences, Inc.
LabCorp Extends Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.
Laboratory Corporation of America® Holdings Announces 2009 Second Quarter Results
Laboratory Corporation of America® Holdings Announces 2009 Second Quarter Results
LabCorp's Acquisition of Monogram Biosciences, Inc. Clears Antitrust Review
ARCA Biopharma Announces Changes to Management Team Reflecting Change in Commercial Strategy
LabCorp Redeems All Outstanding Liquid Yield Option™ Notes Due 2021 and $369.1 Million Principal Amount at Maturity of Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Monogram Biosciences, Inc.
2009 Midyear New-Build Update: Pharmaceutical-Biotech Industry Completes Construction of 40 North American Facilities
LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc.
LabCorp is Scheduled to Present at the William Blair & Company 29th Annual Growth Stock Conference
LabCorp to Strengthen Capital Structure by Redeeming Convertible Debt
LabCorp is Scheduled to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
LabCorp Announces David P. King Elected Chairman of the Board
LabCorp® Scheduled to Webcast Its Annual Meeting of Stockholders
Laboratory Corporation of America® Holdings Announces 2009 First Quarter Results
Laboratory Corporation of America® Holdings Announces 2009 First Quarter Results
LabCorp is Scheduled to Present at the Barclays Capital Global Healthcare Conference
LabCorp Announces Appointment of Dr. Mark Elliott Brecher As Chief Medical Officer
LabCorp is the First National Commercial Lab to Offer Roche’s COBAS® AmpliPrep/COBAS® TaqMan® HCV Test
Laboratory Corporation of America® Holdings Announces 2008 Fourth Quarter and Full Year Results
ARCA Biopharma, Inc. Announces Commencement of Trading on the NASDAQ Global Market Under the Symbol "ABIO"
ARCA Biopharma and Nuvelo Complete Merger Creating Late-Stage Cardiovascular Company - Jan 28 2009 1:22AM
Lockerbie & Hole Announces Project Delay - Jan 21 2009 7:35PM
Lockerbie & Hole Announces Record Fiscal 2009 Third Quarter Results
ARCA Biopharma Appoints Derek Cole As Vice President, Investor Relations and Corporate Communications
LabCorp is Scheduled to Present at the 27th Annual J.P. Morgan Healthcare Conference
Lockerbie & Hole announces Q3 2009 results release date and conference call
BenchmarkJournal.Com (Complimentary) Analyst Review for LH, TS, BMC and GPN
LabCorp To Present at the Goldman Sachs Healthcare Conference – Reiterates 2008 Guidance and Updates Preliminary 2009 Guidance
National Jewish Health and LabCorp to Collaborate on Companion Diagnostics Opportunities
Exact Sciences Receives Communication From NASDAQ on Listing Status - Nov 26 2008 10:23AM
LabCorp is Scheduled to Present at the 20th Annual Piper Jaffray Health Care Conference
Lockerbie & Hole Announces Project Delay - Nov 19 2008 9:03PM
LabCorp Launches Tumor MGMT Gene Methylation Testing
Lockerbie & Hole Reports Purchases Under Normal Course Issuer Bid
LabCorp is Scheduled to Present at the Credit Suisse 2008 Global Healthcare Conference
LabCorp to be the First National Commercial Lab to Offer Roche's COBAS(R) TaqMan(R) HBV Test
Mubadala Healthcare and Laboratory Corporation of America Holdings Agree to Establish a National Reference Laboratory in Abu Dhabi
Seven Summits Research Releases Alerts on HD, AMGN, NUE, FDX, and LH
Investment Industry Regulatory Organization of Canada - Trade Resumption - Lockerbie & Hole Inc. - LH
Lockerbie & Hole Announces Project Delay - Oct 24 2008 1:47PM
Investment Industry Regulatory Organization of Canada - Trading Halt - Lockerbie & Hole - LH
Laboratory Corporation of America(R) Holdings Announces 2008 Third Quarter Results
Lockerbie & Hole Implements a Normal Course Issuer Bid
Lockerbie & Hole Announces Fiscal 2009 Second Quarter Results
Lockerbie & Hole announces Q2 2009 results release date and conference call
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 - Oct 2 2008 2:16AM
FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
LabCorp is Scheduled to Present at the UBS 2008 Global Life Sciences Conference
LabCorp is Scheduled to Present at the Bank of America 38th Annual Investment Conference
LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
LabCorp is Scheduled to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
LabCorp Launches Chronic Kidney Disease Program
Laboratory Corporation of America(R) Holdings Announces 2008 Second Quarter Results
Personalized Medicine Coalition Announces Two New Board Members
Lockerbie & Hole Awarded a Contract by TransCanada Keystone Pipeline Limited Partnership
LabCorp Announces Availability of ColoSure(TM)
Lockerbie & Hole Announces 2009 First Quarter Results
Lockerbie & Hole announces Q1 2009 results release date and conference call
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 - Jul 1 2008 7:16AM
LabCorp Announces Availability of OvaSure(TM)
LabCorp is Scheduled to Present at the 18th Annual Wachovia Nantucket Equity Conference
LabCorp is Scheduled to Present at the Jefferies 2nd Annual Healthcare Conference
Wall Street Media Presents Two CEO Presentation Video Highlights
LabCorp Is Scheduled to Present at the William Blair & Company 28th Annual Growth Stock Conference
LabCorp is Scheduled to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests - Business Wire
LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests - PR Newswire
Lockerbie & Hole Awarded a Contract for the Fort Hills Oil Sands Project
Lockerbie & Hole Announces 2008 Fourth Quarter and Year End Results
Lockerbie & Hole Selected as the Mechanical Construction Manager for Edmonton's New Remand Centre
Lockerbie & Hole Selected as the Design Build Contractor for Suncor Voyageur Water and Wastewater Treatment Plants - May 27 2008 12:43AM
Lockerbie & Hole announces Q4 2008 results release date and conference call - May 27 2008 1:34AM
LabCorp First Company to Commercially Launch Gene Methylation Test for Prostate Cancer - May 27 2008 12:55AM
LabCorp is Scheduled to Present at the Bank of America 2008 Health Care Conference - Jun 2 2008 12:14AM
Laboratory Corporation of America(R) Holdings Announces 2008 First Quarter Results
Stock Alert for MIHS! April 10, 2008
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 - Jun 2 2008 12:13AM
CheckUps Clinics to Provide Specimen Collection Services for LabCorp
Laboratory Corporation of America(R) Holdings Announces 2007 First Quarter Results